ScholarIQanswers from OpenAlex & ORCID
Ciro Tetta
ResearcherPublications, citations & collaboration network
Ciro Tetta is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Ciro Tetta have?
ScholarIQindexed works
Ciro Tetta has 449 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Ciro Tetta have?
ScholarIQcitation count
Ciro Tetta has 26,729 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Ciro Tetta?
ScholarIQh-index
Ciro Tetta has an h-index of 79 in OpenAlex.
What is the i10-index of Ciro Tetta?
ScholarIQi10-index
Ciro Tetta has an i10-index of 236 in OpenAlex.
What is the OpenAlex record for Ciro Tetta?
ScholarIQopenalex
The OpenAlex for Ciro Tetta is on the source record.
What are the most-cited papers on Ciro Tetta?
ScholarIQmost cited works
Review on uremic toxins: Classification, concentration, and interindividual variability
Raymond Vanholder, For the European Uremic Toxin Work Group (EUTox), Rita De Smet, Griet Glorieux, Àngel Argilés, U. Baurmeister, Philippe Brunet, William R. Clark, Gerald Cohen, Peter Paul De Deyn, Reinhold Deppisch, Béatrice Descamps‐Latscha, Thomas Henle, Achim Jörres, H.‐D. Lemke, Ziad A. Massy, Jutta Passlick‐Deetjen, Mariano Rodríguez, Bernd Stegmayr, Peter Stenvinkel, Ciro Tetta, Christoph Wanner, Walter Zidek
Recent advances in 2D and 3D in vitro systems using primary hepatocytes, alternative hepatocyte sources and non-parenchymal liver cells and their use in investigating mechanisms of hepatotoxicity, cell signaling and ADME
Patrício Godoy, Nicola J. Hewitt, Ute Albrecht, Melvin E. Andersen, Nariman Ansari, Sudin Bhattacharya, Johannes G. Bode, Jennifer Bolleyn, Christoph Borner, J Böttger, Albert Braeuning, Robert A. Budinsky, Britta Burkhardt, Neil R. Cameron, Giovanni Camussi, Chong-Su Cho, Yun-Jaie Choi, J. Craig Rowlands, Uta Dahmen, Georg Damm, Olaf Dirsch, M. Teresa Donato, Jian Dong, Steven Dooley, Dirk Drasdo, Rowena Eakins, Karine Sá Ferreira, Valentina Fonsato, Joanna Fraczek, Rolf Gebhardt, Andrew Gibson, Matthias Glanemann, Christopher E. Goldring, Marı́a José Gómez-Lechón, Geny M. M. Groothuis, Lena Gustavsson, Christelle Guyot, David Hallifax, Seddik Hammad, Adam S. Hayward, Dieter Häussinger, Claus Hellerbrand, Philip Hewitt, Stefan Hoehme, Hermann−Georg Holzhütter, J. Brian Houston, Jens Hrach, Kiyomi Ito, Hartmut Jaeschke, Verena Keitel, Jens Kelm, B. Kevin Park, Claus Kordes, Gerd A. Kullak‐Ublick, Edward L. LeCluyse, Peng Lü, Jennifer L. Luebke-Wheeler, Anna Lutz, Daniel J. Maltman, Madlen Matz‐Soja, Patrick D. McMullen, Irmgard Merfort, Simon Messner, Christoph Meyer, Jessica Mwinyi, Dean J. Naisbitt, Andreas K. Nüssler, Peter Olinga, Francesco Pampaloni, Jingbo Pi, Linda Pluta, Stefan Przyborski, Anup Ramachandran, Vera Rogiers, Cliff Rowe, Celine Schelcher, Kathrin Schmich, Michael Schwarz, Bijay Singh, Ernst H. K. Stelzer, Bruno Stieger, Regina Stöber, Yuichi Sugiyama, Ciro Tetta, Wolfgang E. Thasler, Tamara Vanhaecke, Mathieu Vinken, Thomas S. Weiß, A Widera, Courtney G. Woods, Jinghai J. Xu, Kathy Yarborough, Jan G. Hengstler
Chronic inflammation and mortality in haemodialysis: effect of different renal replacement therapies. Results from the RISCAVID study
Vincenzo Panichi, Giovanni Manca Rizza, Sabrina Paoletti, Roberto Bigazzi, Marta Aloisi, Giovanni Barsotti, P Rindi, Gabriele Donati, Alessandro Antonelli, Erica Panicucci, Giovanni Tripepi, Ciro Tetta, Roberto Palla, on behalf of the RISCAVID Study Group